The current valuation score of Ultragenyx Pharmaceutical Inc is 6.12, ranking 137 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -4.08, which is -22.30% below the recent high of -3.17 and -122.74% above the recent low of -9.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.